BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36049057)

  • 1. Evaluation of EDB Fibronectin in Plasma, Patient-Derived Xenograft Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tumor Tissues Using Immunoaffinity LC-MS/MS.
    Li F; Hooper AT; Golas J; Chang CB; Neubert H; King L
    J Proteome Res; 2022 Oct; 21(10):2331-2340. PubMed ID: 36049057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipeptide Immunocapture with In-Sample Calibration Curve Strategy for Sensitive and Robust LC-MS/MS Bioanalysis of Clinical Protein Biomarkers in Formalin-Fixed Paraffin-Embedded Tumor Tissues.
    Zheng N; Taylor K; Gu H; Santockyte R; Wang XT; McCarty J; Adelakun O; Zhang YJ; Pillutla R; Zeng J
    Anal Chem; 2020 Nov; 92(21):14713-14722. PubMed ID: 33047598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin.
    Vaidya A; Ayat N; Buford M; Wang H; Shankardass A; Zhao Y; Gilmore H; Wang Z; Lu ZR
    Theranostics; 2020; 10(24):11127-11143. PubMed ID: 33042274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Assessment of the Effectiveness of Magnetic Resonance Molecular Imaging of Extradomain-B Fibronectin for Detection and Characterization of Oral Cancer.
    Hall RC; Ayat NR; Qiao PL; Vaidya AM; Ma D; Aminoshariae A; Stojanov I; Lu ZR
    Mol Imaging Biol; 2020 Dec; 22(6):1532-1542. PubMed ID: 32789648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.
    Kennedy JJ; Whiteaker JR; Kennedy LC; Bosch DE; Lerch ML; Schoenherr RM; Zhao L; Lin C; Chowdhury S; Kilgore MR; Allison KH; Wang P; Hoofnagle AN; Baird GS; Paulovich AG
    Clin Chem; 2021 Jul; 67(7):1008-1018. PubMed ID: 34136904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
    Hooper AT; Marquette K; Chang CB; Golas J; Jain S; Lam MH; Guffroy M; Leal M; Falahatpisheh H; Mathur D; Chen T; Kelleher K; Khandke K; Muszynska E; Loganzo F; Rosfjord E; Lucas J; Kan Z; Subramanyam C; O'Donnell C; Neri D; Gerber HP; May C; Sapra P
    Mol Cancer Ther; 2022 Sep; 21(9):1462-1472. PubMed ID: 35793468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells.
    Vaidya A; Wang H; Qian V; Gilmore H; Lu ZR
    Cells; 2020 Aug; 9(8):. PubMed ID: 32756405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma.
    Saw PE; Xu X; Kang BR; Lee J; Lee YS; Kim C; Kim H; Kang SH; Na YJ; Moon HJ; Kim JH; Park YK; Yoon W; Kim JH; Kwon TH; Choi C; Jon S; Chong K
    Theranostics; 2021; 11(2):941-957. PubMed ID: 33391514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis.
    Qiao PL; Gargesha M; Liu Y; Laney VEA; Hall RC; Vaidya AM; Gilmore H; Gawelek K; Scott BB; Roy D; Wilson DL; Lu ZR
    Magn Reson Imaging; 2022 Feb; 86():37-45. PubMed ID: 34801672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis.
    Sprung RW; Brock JW; Tanksley JP; Li M; Washington MK; Slebos RJ; Liebler DC
    Mol Cell Proteomics; 2009 Aug; 8(8):1988-98. PubMed ID: 19467989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.
    Coltrini D; Ronca R; Belleri M; Zardi L; Indraccolo S; Scarlato V; Giavazzi R; Presta M
    J Pathol; 2009 Dec; 219(4):455-62. PubMed ID: 19824060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly Accurate and Robust Absolute Quantification of Target Proteins in Formalin-Fixed Paraffin-Embedded (FFPE) Tissues by LC-MS.
    Pu J; Xue C; Huo S; Shen Q; Qu Y; Yang X; An B; Angel TE; Chen Z; Mehl JT; Tang H; Yang E; Sikorski TW; Qu J
    Anal Chem; 2023 Jan; 95(2):924-934. PubMed ID: 36534410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative protein profiling of phenobarbital-induced drug metabolizing enzymes in rat liver by liquid chromatography mass spectrometry using formalin-fixed paraffin-embedded samples.
    Yamauchi H; Andou T; Watanabe T; Gotou M; Anayama H
    J Pharmacol Toxicol Methods; 2021; 112():107107. PubMed ID: 34363961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of two methods for LC-MS/MS proteomic analysis of formalin fixed and paraffin embedded tissues.
    Davalieva K; Kiprijanovska S; Dimovski A; Rosoklija G; Dwork AJ
    J Proteomics; 2021 Mar; 235():104117. PubMed ID: 33453434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted metabolomics in formalin-fixed paraffin-embedded tissue specimens: Liquid chromatography-tandem mass spectrometry determination of acidic metabolites in cancer research.
    Gomez-Gomez A; Sabbaghi M; Haro N; Albanell J; Menéndez S; González M; Gil-Gómez G; Rovira A; Pozo OJ
    Talanta; 2021 Feb; 223(Pt 2):121740. PubMed ID: 33298266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
    Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
    Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI of breast tumor initiating cells using the extra domain-B of fibronectin targeting nanoparticles.
    Sun Y; Kim HS; Park J; Li M; Tian L; Choi Y; Choi BI; Jon S; Moon WK
    Theranostics; 2014; 4(8):845-57. PubMed ID: 24955145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/MS: assay development for total salivary pepsin/pepsinogen.
    Neubert H; Gale J; Muirhead D
    Clin Chem; 2010 Sep; 56(9):1413-23. PubMed ID: 20472821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EDB Fibronectin-Specific SPECT Probe
    Ye XX; Zhao YY; Wang Q; Xiao W; Zhao J; Peng YJ; Cao DH; Lin WJ; Si-Tu MY; Li MZ; Zhang X; Zhang WG; Xia YF; Yang X; Feng GK; Zeng MS
    ACS Omega; 2017 Jun; 2(6):2459-2468. PubMed ID: 30023665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of fibronectin isoforms in human breast tissue: production of extra domain A+/extra domain B+ by cancer cells and extra domain A+ by stromal cells.
    Matsumoto E; Yoshida T; Kawarada Y; Sakakura T
    Jpn J Cancer Res; 1999 Mar; 90(3):320-5. PubMed ID: 10359047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.